BioAdaptives, Inc.
corporate_fare Company Profile
BioAdaptives, Inc. (OTC:BDPT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 5 items for BDPT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-19, rated 8/10. Across its 5 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for BDPT spans 10-Q, 10-K.
Recent high-impact activity:
- BioAdaptives Q2 10-Q: Going Concern, Cash Crunch, and Massive Dilution from Debt Conversions
- BioAdaptives' MyndSystem™ Achieves Full WADA Compliance, Unlocking Pro Athlete Market
- BioAdaptives Posts Initial $5.51K Revenue in Q1, Net Loss Improves
- BIOADAPTIVES Reports Q1 Loss, Going Concern, Material Weakness, and Default on Senior Debt
- Annual Report Reveals Substantial Doubt About Going Concern, Mounting Losses, and Highly Dilutive Financing
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 2,876 shares in BDPT as of the September 15, 2026 settlement, a 100.0% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 52.5% of BDPT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.